Laddar...
Mechanisms of Taxol resistance related to microtubules
Since its approval by the FDA in 1992 for the treatment of ovarian cancer, the use of Taxol has dramatically increased. Although treatment with Taxol has led to improvement in the duration and quality of life for some cancer patients, the majority eventually develop progressive disease after initial...
Sparad:
| Huvudupphovsmän: | , , , |
|---|---|
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Publicerad: |
2003
|
| Ämnen: | |
| Länkar: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4039039/ https://ncbi.nlm.nih.gov/pubmed/14576838 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/sj.onc.1206934 |
| Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|